Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001503785 | SCV001708643 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2020-02-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235436 | SCV003934313 | likely benign | not specified | 2023-05-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004319 | SCV004829296 | likely benign | Marfan syndrome | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004619461 | SCV005113196 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |